Bell Investment Advisors, Inc Zai Lab LTD Transaction History

Bell Investment Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$22.28 - $38.71 $467 - $812	-21 Reduced 61.76%	13 $0
Q3 2022 Nov 09, 2022	BUY	$34.2 - $51.69 $718 - $1,085	21 Added 161.54%	34 $1,000
Q2 2022 Aug 12, 2022	BUY	$23.14 - $49.68 $138 - $298	6 Added 85.71%	13 $0
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $384 - $736	7 New	7 $0

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.52B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Bell Investment Advisors, Inc with notifications on news.